nodes	percent_of_prediction	percent_of_DWPC	metapath
Escitalopram—Gagging—Levothyroxine—hypothyroidism	0.0333	0.0392	CcSEcCtD
Escitalopram—Gagging—Dextrothyroxine—hypothyroidism	0.0333	0.0392	CcSEcCtD
Escitalopram—Choking—Dextrothyroxine—hypothyroidism	0.0282	0.0332	CcSEcCtD
Escitalopram—Choking—Levothyroxine—hypothyroidism	0.0282	0.0332	CcSEcCtD
Escitalopram—Gagging—Liotrix—hypothyroidism	0.0245	0.0288	CcSEcCtD
Escitalopram—Choking—Liotrix—hypothyroidism	0.0208	0.0244	CcSEcCtD
Escitalopram—Retching—Levothyroxine—hypothyroidism	0.0151	0.0177	CcSEcCtD
Escitalopram—Retching—Dextrothyroxine—hypothyroidism	0.0151	0.0177	CcSEcCtD
Escitalopram—Acute bronchitis—Liotrix—hypothyroidism	0.0145	0.0171	CcSEcCtD
Escitalopram—Hyperthyroidism—Levothyroxine—hypothyroidism	0.013	0.0153	CcSEcCtD
Escitalopram—Hyperthyroidism—Dextrothyroxine—hypothyroidism	0.013	0.0153	CcSEcCtD
Escitalopram—Tracheobronchitis—Liotrix—hypothyroidism	0.0126	0.0148	CcSEcCtD
Escitalopram—Tetany—Liotrix—hypothyroidism	0.0116	0.0137	CcSEcCtD
Escitalopram—Retching—Liotrix—hypothyroidism	0.0111	0.0131	CcSEcCtD
Escitalopram—Muscle twitching—Liothyronine—hypothyroidism	0.0107	0.0126	CcSEcCtD
Escitalopram—CYP2C19—urine—hypothyroidism	0.00974	0.126	CbGeAlD
Escitalopram—Hyperthyroidism—Liotrix—hypothyroidism	0.00959	0.0113	CcSEcCtD
Escitalopram—Menstruation irregular—Levothyroxine—hypothyroidism	0.00931	0.011	CcSEcCtD
Escitalopram—Menstruation irregular—Dextrothyroxine—hypothyroidism	0.00931	0.011	CcSEcCtD
Escitalopram—SLC6A3—nerve—hypothyroidism	0.00886	0.115	CbGeAlD
Escitalopram—Phlebitis—Liothyronine—hypothyroidism	0.00884	0.0104	CcSEcCtD
Escitalopram—Abdominal bloating—Liotrix—hypothyroidism	0.00796	0.00937	CcSEcCtD
Escitalopram—Throat tightness—Liotrix—hypothyroidism	0.00773	0.00909	CcSEcCtD
Escitalopram—Abdominal cramps—Dextrothyroxine—hypothyroidism	0.00763	0.00898	CcSEcCtD
Escitalopram—Abdominal cramps—Levothyroxine—hypothyroidism	0.00763	0.00898	CcSEcCtD
Escitalopram—Epigastric discomfort—Liotrix—hypothyroidism	0.00721	0.00848	CcSEcCtD
Escitalopram—SLC6A2—nerve—hypothyroidism	0.00714	0.0925	CbGeAlD
Escitalopram—Menstruation irregular—Liotrix—hypothyroidism	0.00685	0.00806	CcSEcCtD
Escitalopram—Angina pectoris—Liothyronine—hypothyroidism	0.00641	0.00755	CcSEcCtD
Escitalopram—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00579	0.00681	CcSEcCtD
Escitalopram—CYP3A4—urine—hypothyroidism	0.00576	0.0746	CbGeAlD
Escitalopram—Myocardial infarction—Liothyronine—hypothyroidism	0.00575	0.00677	CcSEcCtD
Escitalopram—CYP2D6—urine—hypothyroidism	0.00567	0.0734	CbGeAlD
Escitalopram—Abdominal cramps—Liotrix—hypothyroidism	0.00561	0.00661	CcSEcCtD
Escitalopram—Cyanosis—Liotrix—hypothyroidism	0.00535	0.0063	CcSEcCtD
Escitalopram—SLC6A4—Monoamine Transport—SLC5A7—hypothyroidism	0.00527	0.0722	CbGpPWpGaD
Escitalopram—Wheezing—Levothyroxine—hypothyroidism	0.005	0.00589	CcSEcCtD
Escitalopram—Wheezing—Dextrothyroxine—hypothyroidism	0.005	0.00589	CcSEcCtD
Escitalopram—Coagulopathy—Liotrix—hypothyroidism	0.00487	0.00573	CcSEcCtD
Escitalopram—Feeling hot—Liotrix—hypothyroidism	0.00483	0.00568	CcSEcCtD
Escitalopram—Abscess—Liotrix—hypothyroidism	0.00479	0.00564	CcSEcCtD
Escitalopram—SLC6A2—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00477	0.0654	CbGpPWpGaD
Escitalopram—Coma—Dextrothyroxine—hypothyroidism	0.00471	0.00554	CcSEcCtD
Escitalopram—Coma—Levothyroxine—hypothyroidism	0.00471	0.00554	CcSEcCtD
Escitalopram—Arrhythmia—Liothyronine—hypothyroidism	0.00471	0.00554	CcSEcCtD
Escitalopram—SLC6A2—Monoamine Transport—SLC5A7—hypothyroidism	0.00453	0.0621	CbGpPWpGaD
Escitalopram—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.00449	0.00529	CcSEcCtD
Escitalopram—Hyperkinesia—Levothyroxine—hypothyroidism	0.00449	0.00529	CcSEcCtD
Escitalopram—SLC6A3—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00422	0.0579	CbGpPWpGaD
Escitalopram—Disorientation—Dextrothyroxine—hypothyroidism	0.00418	0.00492	CcSEcCtD
Escitalopram—Disorientation—Levothyroxine—hypothyroidism	0.00418	0.00492	CcSEcCtD
Escitalopram—Cellulitis—Liotrix—hypothyroidism	0.00417	0.0049	CcSEcCtD
Escitalopram—Hypocalcaemia—Liotrix—hypothyroidism	0.00414	0.00487	CcSEcCtD
Escitalopram—Oliguria—Liotrix—hypothyroidism	0.00411	0.00484	CcSEcCtD
Escitalopram—SLC6A3—Monoamine Transport—SLC5A7—hypothyroidism	0.00401	0.055	CbGpPWpGaD
Escitalopram—Increased appetite—Levothyroxine—hypothyroidism	0.00398	0.00468	CcSEcCtD
Escitalopram—Increased appetite—Dextrothyroxine—hypothyroidism	0.00398	0.00468	CcSEcCtD
Escitalopram—Hypertension—Liothyronine—hypothyroidism	0.00396	0.00466	CcSEcCtD
Escitalopram—Muscle twitching—Liotrix—hypothyroidism	0.00386	0.00454	CcSEcCtD
Escitalopram—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00383	0.00451	CcSEcCtD
Escitalopram—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00383	0.00451	CcSEcCtD
Escitalopram—Cardiac failure—Levothyroxine—hypothyroidism	0.00383	0.00451	CcSEcCtD
Escitalopram—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00383	0.00451	CcSEcCtD
Escitalopram—Affect lability—Levothyroxine—hypothyroidism	0.00368	0.00433	CcSEcCtD
Escitalopram—Affect lability—Dextrothyroxine—hypothyroidism	0.00368	0.00433	CcSEcCtD
Escitalopram—Wheezing—Liotrix—hypothyroidism	0.00368	0.00433	CcSEcCtD
Escitalopram—Tachycardia—Liothyronine—hypothyroidism	0.00365	0.0043	CcSEcCtD
Escitalopram—Fluid retention—Liotrix—hypothyroidism	0.0036	0.00423	CcSEcCtD
Escitalopram—Irritability—Levothyroxine—hypothyroidism	0.00357	0.0042	CcSEcCtD
Escitalopram—Irritability—Dextrothyroxine—hypothyroidism	0.00357	0.0042	CcSEcCtD
Escitalopram—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00356	0.00419	CcSEcCtD
Escitalopram—Cardiac arrest—Levothyroxine—hypothyroidism	0.00356	0.00419	CcSEcCtD
Escitalopram—Mood swings—Levothyroxine—hypothyroidism	0.00354	0.00417	CcSEcCtD
Escitalopram—Mood swings—Dextrothyroxine—hypothyroidism	0.00354	0.00417	CcSEcCtD
Escitalopram—Hypotension—Liothyronine—hypothyroidism	0.0035	0.00412	CcSEcCtD
Escitalopram—Dehydration—Dextrothyroxine—hypothyroidism	0.00348	0.00409	CcSEcCtD
Escitalopram—Dehydration—Levothyroxine—hypothyroidism	0.00348	0.00409	CcSEcCtD
Escitalopram—Coma—Liotrix—hypothyroidism	0.00346	0.00408	CcSEcCtD
Escitalopram—Lightheadedness—Liotrix—hypothyroidism	0.00339	0.00399	CcSEcCtD
Escitalopram—Hyperkinesia—Liotrix—hypothyroidism	0.00331	0.00389	CcSEcCtD
Escitalopram—Muscular weakness—Dextrothyroxine—hypothyroidism	0.0033	0.00388	CcSEcCtD
Escitalopram—Muscular weakness—Levothyroxine—hypothyroidism	0.0033	0.00388	CcSEcCtD
Escitalopram—Sepsis—Liotrix—hypothyroidism	0.00329	0.00387	CcSEcCtD
Escitalopram—Dysphagia—Dextrothyroxine—hypothyroidism	0.00323	0.0038	CcSEcCtD
Escitalopram—Dysphagia—Levothyroxine—hypothyroidism	0.00323	0.0038	CcSEcCtD
Escitalopram—Phlebitis—Liotrix—hypothyroidism	0.00319	0.00376	CcSEcCtD
Escitalopram—Sweating increased—Dextrothyroxine—hypothyroidism	0.00315	0.00371	CcSEcCtD
Escitalopram—Angina pectoris—Levothyroxine—hypothyroidism	0.00315	0.00371	CcSEcCtD
Escitalopram—Angina pectoris—Dextrothyroxine—hypothyroidism	0.00315	0.00371	CcSEcCtD
Escitalopram—Sweating increased—Levothyroxine—hypothyroidism	0.00315	0.00371	CcSEcCtD
Escitalopram—Disorientation—Liotrix—hypothyroidism	0.00308	0.00362	CcSEcCtD
Escitalopram—Renal failure acute—Liotrix—hypothyroidism	0.00298	0.00351	CcSEcCtD
Escitalopram—Body temperature increased—Liothyronine—hypothyroidism	0.00296	0.00348	CcSEcCtD
Escitalopram—Increased appetite—Liotrix—hypothyroidism	0.00293	0.00345	CcSEcCtD
Escitalopram—Weight decreased—Levothyroxine—hypothyroidism	0.00292	0.00344	CcSEcCtD
Escitalopram—Weight decreased—Dextrothyroxine—hypothyroidism	0.00292	0.00344	CcSEcCtD
Escitalopram—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00284	0.00334	CcSEcCtD
Escitalopram—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00284	0.00334	CcSEcCtD
Escitalopram—CHRM1—cardiovascular system—hypothyroidism	0.00283	0.0367	CbGeAlD
Escitalopram—Myocardial infarction—Levothyroxine—hypothyroidism	0.00283	0.00332	CcSEcCtD
Escitalopram—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00283	0.00332	CcSEcCtD
Escitalopram—Hypoglycaemia—Liotrix—hypothyroidism	0.00282	0.00332	CcSEcCtD
Escitalopram—Cardiac failure—Liotrix—hypothyroidism	0.00282	0.00332	CcSEcCtD
Escitalopram—Cerebrovascular accident—Liotrix—hypothyroidism	0.00281	0.0033	CcSEcCtD
Escitalopram—Sweating—Dextrothyroxine—hypothyroidism	0.00276	0.00325	CcSEcCtD
Escitalopram—Sweating—Levothyroxine—hypothyroidism	0.00276	0.00325	CcSEcCtD
Escitalopram—Affect lability—Liotrix—hypothyroidism	0.00271	0.00319	CcSEcCtD
Escitalopram—Irritability—Liotrix—hypothyroidism	0.00263	0.00309	CcSEcCtD
Escitalopram—Cardiac arrest—Liotrix—hypothyroidism	0.00262	0.00308	CcSEcCtD
Escitalopram—Mood swings—Liotrix—hypothyroidism	0.00261	0.00307	CcSEcCtD
Escitalopram—Dehydration—Liotrix—hypothyroidism	0.00256	0.00301	CcSEcCtD
Escitalopram—SLC6A4—Synaptic Vesicle Pathway—CLTC—hypothyroidism	0.00251	0.0345	CbGpPWpGaD
Escitalopram—Hypokalaemia—Liotrix—hypothyroidism	0.0025	0.00295	CcSEcCtD
Escitalopram—ADRA1A—heart—hypothyroidism	0.00247	0.0319	CbGeAlD
Escitalopram—Muscular weakness—Liotrix—hypothyroidism	0.00243	0.00286	CcSEcCtD
Escitalopram—Flushing—Dextrothyroxine—hypothyroidism	0.0024	0.00283	CcSEcCtD
Escitalopram—Flushing—Levothyroxine—hypothyroidism	0.0024	0.00283	CcSEcCtD
Escitalopram—Abdominal distension—Liotrix—hypothyroidism	0.00239	0.00282	CcSEcCtD
Escitalopram—Dysphagia—Liotrix—hypothyroidism	0.00238	0.0028	CcSEcCtD
Escitalopram—Bronchospasm—Liotrix—hypothyroidism	0.00234	0.00275	CcSEcCtD
Escitalopram—ADRA1A—cardiovascular system—hypothyroidism	0.00233	0.0301	CbGeAlD
Escitalopram—Angina pectoris—Liotrix—hypothyroidism	0.00232	0.00273	CcSEcCtD
Escitalopram—Sweating increased—Liotrix—hypothyroidism	0.00232	0.00273	CcSEcCtD
Escitalopram—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00231	0.00272	CcSEcCtD
Escitalopram—Arrhythmia—Levothyroxine—hypothyroidism	0.00231	0.00272	CcSEcCtD
Escitalopram—Bronchitis—Liotrix—hypothyroidism	0.00229	0.00269	CcSEcCtD
Escitalopram—Alopecia—Levothyroxine—hypothyroidism	0.00229	0.00269	CcSEcCtD
Escitalopram—Alopecia—Dextrothyroxine—hypothyroidism	0.00229	0.00269	CcSEcCtD
Escitalopram—SLC6A2—gonad—hypothyroidism	0.00227	0.0294	CbGeAlD
Escitalopram—SLC6A4—blood—hypothyroidism	0.00225	0.0291	CbGeAlD
Escitalopram—Tension—Dextrothyroxine—hypothyroidism	0.00221	0.0026	CcSEcCtD
Escitalopram—Tension—Levothyroxine—hypothyroidism	0.00221	0.0026	CcSEcCtD
Escitalopram—Nervousness—Levothyroxine—hypothyroidism	0.00219	0.00257	CcSEcCtD
Escitalopram—Nervousness—Dextrothyroxine—hypothyroidism	0.00219	0.00257	CcSEcCtD
Escitalopram—Weight decreased—Liotrix—hypothyroidism	0.00215	0.00253	CcSEcCtD
Escitalopram—Tremor—Dextrothyroxine—hypothyroidism	0.00211	0.00248	CcSEcCtD
Escitalopram—Tremor—Levothyroxine—hypothyroidism	0.00211	0.00248	CcSEcCtD
Escitalopram—Acute coronary syndrome—Liotrix—hypothyroidism	0.00209	0.00246	CcSEcCtD
Escitalopram—Myocardial infarction—Liotrix—hypothyroidism	0.00208	0.00245	CcSEcCtD
Escitalopram—Agitation—Levothyroxine—hypothyroidism	0.00207	0.00244	CcSEcCtD
Escitalopram—Agitation—Dextrothyroxine—hypothyroidism	0.00207	0.00244	CcSEcCtD
Escitalopram—Angioedema—Levothyroxine—hypothyroidism	0.00206	0.00242	CcSEcCtD
Escitalopram—Angioedema—Dextrothyroxine—hypothyroidism	0.00206	0.00242	CcSEcCtD
Escitalopram—Sweating—Liotrix—hypothyroidism	0.00203	0.00239	CcSEcCtD
Escitalopram—SLC6A3—testis—hypothyroidism	0.00203	0.0263	CbGeAlD
Escitalopram—Palpitations—Dextrothyroxine—hypothyroidism	0.00199	0.00234	CcSEcCtD
Escitalopram—Palpitations—Levothyroxine—hypothyroidism	0.00199	0.00234	CcSEcCtD
Escitalopram—SLC6A2—adrenal gland—hypothyroidism	0.00198	0.0256	CbGeAlD
Escitalopram—Convulsion—Dextrothyroxine—hypothyroidism	0.00195	0.0023	CcSEcCtD
Escitalopram—Convulsion—Levothyroxine—hypothyroidism	0.00195	0.0023	CcSEcCtD
Escitalopram—Arthralgia—Dextrothyroxine—hypothyroidism	0.00192	0.00226	CcSEcCtD
Escitalopram—Arthralgia—Levothyroxine—hypothyroidism	0.00192	0.00226	CcSEcCtD
Escitalopram—Anxiety—Levothyroxine—hypothyroidism	0.00191	0.00225	CcSEcCtD
Escitalopram—Anxiety—Dextrothyroxine—hypothyroidism	0.00191	0.00225	CcSEcCtD
Escitalopram—Hypoaesthesia—Liotrix—hypothyroidism	0.00189	0.00223	CcSEcCtD
Escitalopram—SLC6A3—cerebellum—hypothyroidism	0.00187	0.0243	CbGeAlD
Escitalopram—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00187	0.0256	CbGpPWpGaD
Escitalopram—CYP2C19—blood—hypothyroidism	0.00186	0.0241	CbGeAlD
Escitalopram—Confusional state—Dextrothyroxine—hypothyroidism	0.00185	0.00218	CcSEcCtD
Escitalopram—Confusional state—Levothyroxine—hypothyroidism	0.00185	0.00218	CcSEcCtD
Escitalopram—ADRA1A—adrenal gland—hypothyroidism	0.00184	0.0238	CbGeAlD
Escitalopram—ADRA1A—blood—hypothyroidism	0.00184	0.0238	CbGeAlD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00182	0.0249	CbGpPWpGaD
Escitalopram—Shock—Levothyroxine—hypothyroidism	0.00181	0.00213	CcSEcCtD
Escitalopram—Shock—Dextrothyroxine—hypothyroidism	0.00181	0.00213	CcSEcCtD
Escitalopram—Tachycardia—Dextrothyroxine—hypothyroidism	0.00179	0.00211	CcSEcCtD
Escitalopram—Tachycardia—Levothyroxine—hypothyroidism	0.00179	0.00211	CcSEcCtD
Escitalopram—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00178	0.00209	CcSEcCtD
Escitalopram—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00178	0.00209	CcSEcCtD
Escitalopram—Flushing—Liotrix—hypothyroidism	0.00177	0.00208	CcSEcCtD
Escitalopram—Arrhythmia—Liotrix—hypothyroidism	0.0017	0.002	CcSEcCtD
Escitalopram—Alopecia—Liotrix—hypothyroidism	0.00168	0.00198	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00167	0.00197	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00167	0.00197	CcSEcCtD
Escitalopram—Insomnia—Dextrothyroxine—hypothyroidism	0.00166	0.00196	CcSEcCtD
Escitalopram—Insomnia—Levothyroxine—hypothyroidism	0.00166	0.00196	CcSEcCtD
Escitalopram—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00165	0.0226	CbGpPWpGaD
Escitalopram—Dyspnoea—Levothyroxine—hypothyroidism	0.00164	0.00193	CcSEcCtD
Escitalopram—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00164	0.00193	CcSEcCtD
Escitalopram—SLC6A2—testis—hypothyroidism	0.00164	0.0212	CbGeAlD
Escitalopram—Flatulence—Liotrix—hypothyroidism	0.00163	0.00192	CcSEcCtD
Escitalopram—Tension—Liotrix—hypothyroidism	0.00163	0.00191	CcSEcCtD
Escitalopram—Dysgeusia—Liotrix—hypothyroidism	0.00162	0.00191	CcSEcCtD
Escitalopram—Nervousness—Liotrix—hypothyroidism	0.00161	0.00189	CcSEcCtD
Escitalopram—Fatigue—Levothyroxine—hypothyroidism	0.00158	0.00187	CcSEcCtD
Escitalopram—Fatigue—Dextrothyroxine—hypothyroidism	0.00158	0.00187	CcSEcCtD
Escitalopram—SLC6A4—NRF2 pathway—SLC5A7—hypothyroidism	0.00156	0.0214	CbGpPWpGaD
Escitalopram—Vision blurred—Liotrix—hypothyroidism	0.00156	0.00184	CcSEcCtD
Escitalopram—Tremor—Liotrix—hypothyroidism	0.00155	0.00183	CcSEcCtD
Escitalopram—Agitation—Liotrix—hypothyroidism	0.00152	0.00179	CcSEcCtD
Escitalopram—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00151	0.00178	CcSEcCtD
Escitalopram—Feeling abnormal—Levothyroxine—hypothyroidism	0.00151	0.00178	CcSEcCtD
Escitalopram—Angioedema—Liotrix—hypothyroidism	0.00151	0.00178	CcSEcCtD
Escitalopram—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.0015	0.00177	CcSEcCtD
Escitalopram—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.0015	0.00177	CcSEcCtD
Escitalopram—Syncope—Liotrix—hypothyroidism	0.00149	0.00175	CcSEcCtD
Escitalopram—Palpitations—Liotrix—hypothyroidism	0.00146	0.00172	CcSEcCtD
Escitalopram—Urticaria—Levothyroxine—hypothyroidism	0.00146	0.00172	CcSEcCtD
Escitalopram—Urticaria—Dextrothyroxine—hypothyroidism	0.00146	0.00172	CcSEcCtD
Escitalopram—CYP2C19—liver—hypothyroidism	0.00146	0.0189	CbGeAlD
Escitalopram—Loss of consciousness—Liotrix—hypothyroidism	0.00146	0.00171	CcSEcCtD
Escitalopram—Body temperature increased—Levothyroxine—hypothyroidism	0.00145	0.00171	CcSEcCtD
Escitalopram—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00145	0.00171	CcSEcCtD
Escitalopram—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00145	0.00171	CcSEcCtD
Escitalopram—Abdominal pain—Levothyroxine—hypothyroidism	0.00145	0.00171	CcSEcCtD
Escitalopram—ADRA1A—liver—hypothyroidism	0.00144	0.0186	CbGeAlD
Escitalopram—Convulsion—Liotrix—hypothyroidism	0.00144	0.00169	CcSEcCtD
Escitalopram—Hypertension—Liotrix—hypothyroidism	0.00143	0.00168	CcSEcCtD
Escitalopram—HRH1—adrenal gland—hypothyroidism	0.00142	0.0184	CbGeAlD
Escitalopram—Chest pain—Liotrix—hypothyroidism	0.00141	0.00166	CcSEcCtD
Escitalopram—Arthralgia—Liotrix—hypothyroidism	0.00141	0.00166	CcSEcCtD
Escitalopram—Anxiety—Liotrix—hypothyroidism	0.00141	0.00165	CcSEcCtD
Escitalopram—ADRA1A—cerebellum—hypothyroidism	0.00141	0.0182	CbGeAlD
Escitalopram—Confusional state—Liotrix—hypothyroidism	0.00136	0.0016	CcSEcCtD
Escitalopram—Anaphylactic shock—Liotrix—hypothyroidism	0.00135	0.00159	CcSEcCtD
Escitalopram—Oedema—Liotrix—hypothyroidism	0.00135	0.00159	CcSEcCtD
Escitalopram—SLC6A2—NRF2 pathway—SLC5A7—hypothyroidism	0.00134	0.0184	CbGpPWpGaD
Escitalopram—Infection—Liotrix—hypothyroidism	0.00134	0.00158	CcSEcCtD
Escitalopram—Shock—Liotrix—hypothyroidism	0.00133	0.00157	CcSEcCtD
Escitalopram—HRH1—female gonad—hypothyroidism	0.00133	0.0172	CbGeAlD
Escitalopram—Tachycardia—Liotrix—hypothyroidism	0.00132	0.00155	CcSEcCtD
Escitalopram—Asthenia—Dextrothyroxine—hypothyroidism	0.00132	0.00155	CcSEcCtD
Escitalopram—Asthenia—Levothyroxine—hypothyroidism	0.00132	0.00155	CcSEcCtD
Escitalopram—Hyperhidrosis—Liotrix—hypothyroidism	0.00131	0.00154	CcSEcCtD
Escitalopram—Pruritus—Levothyroxine—hypothyroidism	0.0013	0.00153	CcSEcCtD
Escitalopram—Pruritus—Dextrothyroxine—hypothyroidism	0.0013	0.00153	CcSEcCtD
Escitalopram—Anorexia—Liotrix—hypothyroidism	0.00129	0.00152	CcSEcCtD
Escitalopram—Hypotension—Liotrix—hypothyroidism	0.00126	0.00149	CcSEcCtD
Escitalopram—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00126	0.00148	CcSEcCtD
Escitalopram—Diarrhoea—Levothyroxine—hypothyroidism	0.00126	0.00148	CcSEcCtD
Escitalopram—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00123	0.00145	CcSEcCtD
Escitalopram—Insomnia—Liotrix—hypothyroidism	0.00122	0.00144	CcSEcCtD
Escitalopram—Paraesthesia—Liotrix—hypothyroidism	0.00121	0.00143	CcSEcCtD
Escitalopram—Dyspnoea—Liotrix—hypothyroidism	0.00121	0.00142	CcSEcCtD
Escitalopram—SLC6A3—NRF2 pathway—SLC5A7—hypothyroidism	0.00119	0.0163	CbGpPWpGaD
Escitalopram—HRH1—testis—hypothyroidism	0.00118	0.0153	CbGeAlD
Escitalopram—Decreased appetite—Liotrix—hypothyroidism	0.00118	0.00138	CcSEcCtD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00117	0.0161	CbGpPWpGaD
Escitalopram—Vomiting—Levothyroxine—hypothyroidism	0.00117	0.00138	CcSEcCtD
Escitalopram—Vomiting—Dextrothyroxine—hypothyroidism	0.00117	0.00138	CcSEcCtD
Escitalopram—Fatigue—Liotrix—hypothyroidism	0.00117	0.00137	CcSEcCtD
Escitalopram—Rash—Levothyroxine—hypothyroidism	0.00116	0.00136	CcSEcCtD
Escitalopram—Rash—Dextrothyroxine—hypothyroidism	0.00116	0.00136	CcSEcCtD
Escitalopram—Dermatitis—Dextrothyroxine—hypothyroidism	0.00116	0.00136	CcSEcCtD
Escitalopram—Dermatitis—Levothyroxine—hypothyroidism	0.00116	0.00136	CcSEcCtD
Escitalopram—Constipation—Liotrix—hypothyroidism	0.00116	0.00136	CcSEcCtD
Escitalopram—Headache—Levothyroxine—hypothyroidism	0.00115	0.00136	CcSEcCtD
Escitalopram—Headache—Dextrothyroxine—hypothyroidism	0.00115	0.00136	CcSEcCtD
Escitalopram—Feeling abnormal—Liotrix—hypothyroidism	0.00111	0.00131	CcSEcCtD
Escitalopram—Gastrointestinal pain—Liotrix—hypothyroidism	0.00111	0.0013	CcSEcCtD
Escitalopram—CYP3A4—blood—hypothyroidism	0.0011	0.0143	CbGeAlD
Escitalopram—Nausea—Dextrothyroxine—hypothyroidism	0.00109	0.00128	CcSEcCtD
Escitalopram—Nausea—Levothyroxine—hypothyroidism	0.00109	0.00128	CcSEcCtD
Escitalopram—CYP2D6—blood—hypothyroidism	0.00108	0.014	CbGeAlD
Escitalopram—Urticaria—Liotrix—hypothyroidism	0.00107	0.00126	CcSEcCtD
Escitalopram—Body temperature increased—Liotrix—hypothyroidism	0.00107	0.00126	CcSEcCtD
Escitalopram—Abdominal pain—Liotrix—hypothyroidism	0.00107	0.00126	CcSEcCtD
Escitalopram—CYP2D6—female gonad—hypothyroidism	0.00101	0.0131	CbGeAlD
Escitalopram—SLC6A4—Circadian rythm related genes—NKX2-1—hypothyroidism	0.001	0.0138	CbGpPWpGaD
Escitalopram—Hypersensitivity—Liotrix—hypothyroidism	0.000996	0.00117	CcSEcCtD
Escitalopram—Asthenia—Liotrix—hypothyroidism	0.00097	0.00114	CcSEcCtD
Escitalopram—Pruritus—Liotrix—hypothyroidism	0.000957	0.00113	CcSEcCtD
Escitalopram—SLC6A3—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.000926	0.0127	CbGpPWpGaD
Escitalopram—Diarrhoea—Liotrix—hypothyroidism	0.000925	0.00109	CcSEcCtD
Escitalopram—CYP2D6—testis—hypothyroidism	0.000896	0.0116	CbGeAlD
Escitalopram—Dizziness—Liotrix—hypothyroidism	0.000894	0.00105	CcSEcCtD
Escitalopram—CYP3A4—liver—hypothyroidism	0.000861	0.0112	CbGeAlD
Escitalopram—Vomiting—Liotrix—hypothyroidism	0.00086	0.00101	CcSEcCtD
Escitalopram—Rash—Liotrix—hypothyroidism	0.000853	0.001	CcSEcCtD
Escitalopram—Dermatitis—Liotrix—hypothyroidism	0.000852	0.001	CcSEcCtD
Escitalopram—CYP2D6—liver—hypothyroidism	0.000848	0.011	CbGeAlD
Escitalopram—SLC6A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000847	0.0116	CbGpPWpGaD
Escitalopram—Headache—Liotrix—hypothyroidism	0.000847	0.000997	CcSEcCtD
Escitalopram—CYP2D6—cerebellum—hypothyroidism	0.000828	0.0107	CbGeAlD
Escitalopram—Nausea—Liotrix—hypothyroidism	0.000803	0.000945	CcSEcCtD
Escitalopram—SLC6A3—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000751	0.0103	CbGpPWpGaD
Escitalopram—SLC6A3—Neuronal System—SLC5A7—hypothyroidism	0.00071	0.00973	CbGpPWpGaD
Escitalopram—SLC6A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000702	0.00963	CbGpPWpGaD
Escitalopram—SLC6A4—NRF2 pathway—SLC5A5—hypothyroidism	0.000625	0.00857	CbGpPWpGaD
Escitalopram—SLC6A3—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.000622	0.00853	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—NKX2-1—hypothyroidism	0.000601	0.00823	CbGpPWpGaD
Escitalopram—SLC6A3—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000597	0.00818	CbGpPWpGaD
Escitalopram—SLC6A2—NRF2 pathway—SLC5A5—hypothyroidism	0.000537	0.00737	CbGpPWpGaD
Escitalopram—HTR2C—G alpha (q) signalling events—TRH—hypothyroidism	0.000533	0.0073	CbGpPWpGaD
Escitalopram—ADRA1A—G alpha (12/13) signalling events—VAV3—hypothyroidism	0.000513	0.00703	CbGpPWpGaD
Escitalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000476	0.00653	CbGpPWpGaD
Escitalopram—SLC6A3—NRF2 pathway—SLC5A5—hypothyroidism	0.000476	0.00653	CbGpPWpGaD
Escitalopram—SLC6A4—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.000467	0.0064	CbGpPWpGaD
Escitalopram—HRH1—G alpha (q) signalling events—TRH—hypothyroidism	0.000462	0.00633	CbGpPWpGaD
Escitalopram—CHRM1—G alpha (q) signalling events—TRH—hypothyroidism	0.00046	0.00631	CbGpPWpGaD
Escitalopram—SLC6A3—Neuronal System—NEFL—hypothyroidism	0.000457	0.00627	CbGpPWpGaD
Escitalopram—ADRA1A—G alpha (q) signalling events—TRH—hypothyroidism	0.000453	0.00621	CbGpPWpGaD
Escitalopram—CHRM1—Regulation of Actin Cytoskeleton—PIK3C2A—hypothyroidism	0.000438	0.00601	CbGpPWpGaD
Escitalopram—SLC6A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000431	0.0059	CbGpPWpGaD
Escitalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000413	0.00566	CbGpPWpGaD
Escitalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000412	0.00564	CbGpPWpGaD
Escitalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—hypothyroidism	0.000405	0.00555	CbGpPWpGaD
Escitalopram—SLC6A3—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000382	0.00523	CbGpPWpGaD
Escitalopram—SLC6A4—Circadian rythm related genes—AVP—hypothyroidism	0.000381	0.00522	CbGpPWpGaD
Escitalopram—SLC6A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000357	0.00489	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000353	0.00484	CbGpPWpGaD
Escitalopram—SLC6A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000339	0.00464	CbGpPWpGaD
Escitalopram—SLC6A3—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000316	0.00433	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000314	0.00431	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000314	0.00431	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000306	0.00419	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000305	0.00418	CbGpPWpGaD
Escitalopram—SLC6A3—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.0003	0.00411	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.0003	0.00411	CbGpPWpGaD
Escitalopram—HTR2C—G alpha (q) signalling events—AVP—hypothyroidism	0.00028	0.00384	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000272	0.00374	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000272	0.00374	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000272	0.00372	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000272	0.00372	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—TRH—hypothyroidism	0.000269	0.00368	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000267	0.00367	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000267	0.00367	CbGpPWpGaD
Escitalopram—SLC6A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000267	0.00366	CbGpPWpGaD
Escitalopram—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000258	0.00354	CbGpPWpGaD
Escitalopram—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.00025	0.00343	CbGpPWpGaD
Escitalopram—HRH1—G alpha (q) signalling events—AVP—hypothyroidism	0.000242	0.00332	CbGpPWpGaD
Escitalopram—CHRM1—G alpha (q) signalling events—AVP—hypothyroidism	0.000242	0.00331	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—TSHB—hypothyroidism	0.000239	0.00328	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—TSHR—hypothyroidism	0.000239	0.00328	CbGpPWpGaD
Escitalopram—ADRA1A—G alpha (q) signalling events—AVP—hypothyroidism	0.000238	0.00326	CbGpPWpGaD
Escitalopram—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000238	0.00326	CbGpPWpGaD
Escitalopram—SLC6A3—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000236	0.00324	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—TRH—hypothyroidism	0.000233	0.00319	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—TRH—hypothyroidism	0.000232	0.00318	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—TRH—hypothyroidism	0.000228	0.00313	CbGpPWpGaD
Escitalopram—CHRM1—Circadian rythm related genes—AVP—hypothyroidism	0.000228	0.00313	CbGpPWpGaD
Escitalopram—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000217	0.00297	CbGpPWpGaD
Escitalopram—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000216	0.00296	CbGpPWpGaD
Escitalopram—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000213	0.00292	CbGpPWpGaD
Escitalopram—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000209	0.00287	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—TSHB—hypothyroidism	0.000207	0.00284	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—TSHR—hypothyroidism	0.000207	0.00284	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—TSHB—hypothyroidism	0.000207	0.00284	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—TSHR—hypothyroidism	0.000207	0.00284	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—TSHB—hypothyroidism	0.000204	0.00279	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—TSHR—hypothyroidism	0.000204	0.00279	CbGpPWpGaD
Escitalopram—CYP2D6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000193	0.00264	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000185	0.00254	CbGpPWpGaD
Escitalopram—SLC6A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000172	0.00236	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000161	0.0022	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.00016	0.00219	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000158	0.00216	CbGpPWpGaD
Escitalopram—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000155	0.00213	CbGpPWpGaD
Escitalopram—SLC6A3—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000152	0.00209	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—TRH—hypothyroidism	0.000152	0.00208	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—AVP—hypothyroidism	0.000141	0.00193	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—TRH—hypothyroidism	0.000138	0.00189	CbGpPWpGaD
Escitalopram—SLC6A2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000136	0.00186	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—TSHB—hypothyroidism	0.000135	0.00186	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—TSHR—hypothyroidism	0.000135	0.00186	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—TRH—hypothyroidism	0.000132	0.0018	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—IYD—hypothyroidism	0.000131	0.0018	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—TRH—hypothyroidism	0.000131	0.0018	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—TRH—hypothyroidism	0.000129	0.00177	CbGpPWpGaD
Escitalopram—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000126	0.00173	CbGpPWpGaD
Escitalopram—HTR2C—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000123	0.00169	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—TSHB—hypothyroidism	0.000123	0.00168	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—TSHR—hypothyroidism	0.000123	0.00168	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—AVP—hypothyroidism	0.000122	0.00168	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—AVP—hypothyroidism	0.000122	0.00167	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—IYD—hypothyroidism	0.000121	0.00166	CbGpPWpGaD
Escitalopram—SLC6A3—Transmembrane transport of small molecules—AVP—hypothyroidism	0.00012	0.00165	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—AVP—hypothyroidism	0.00012	0.00165	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—TRH—hypothyroidism	0.000119	0.00164	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—TRH—hypothyroidism	0.000119	0.00163	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—TSHB—hypothyroidism	0.000117	0.00161	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—TSHR—hypothyroidism	0.000117	0.00161	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—TRH—hypothyroidism	0.000117	0.00161	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—TSHB—hypothyroidism	0.000117	0.0016	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—TSHR—hypothyroidism	0.000117	0.0016	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—TSHB—hypothyroidism	0.000115	0.00158	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—TSHR—hypothyroidism	0.000115	0.00158	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—ATP5O—hypothyroidism	0.000112	0.00153	CbGpPWpGaD
Escitalopram—CYP2C19—Biological oxidations—POMC—hypothyroidism	0.000111	0.00153	CbGpPWpGaD
Escitalopram—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000107	0.00146	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—TSHB—hypothyroidism	0.000106	0.00146	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—TSHR—hypothyroidism	0.000106	0.00146	CbGpPWpGaD
Escitalopram—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000106	0.00146	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—TSHB—hypothyroidism	0.000106	0.00146	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—TSHR—hypothyroidism	0.000106	0.00146	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—TPO—hypothyroidism	0.000105	0.00144	CbGpPWpGaD
Escitalopram—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000105	0.00144	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—TSHR—hypothyroidism	0.000104	0.00143	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—TSHB—hypothyroidism	0.000104	0.00143	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—ATP5O—hypothyroidism	0.000103	0.00141	CbGpPWpGaD
Escitalopram—CYP2D6—Biological oxidations—POMC—hypothyroidism	0.000102	0.0014	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	9.72e-05	0.00133	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—TPO—hypothyroidism	9.65e-05	0.00132	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—CLTC—hypothyroidism	9.42e-05	0.00129	CbGpPWpGaD
Escitalopram—HTR2C—GPCR ligand binding—POMC—hypothyroidism	9.38e-05	0.00129	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—VAV3—hypothyroidism	8.28e-05	0.00113	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—CLTC—hypothyroidism	8.17e-05	0.00112	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TRH—hypothyroidism	8.14e-05	0.00112	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—CLTC—hypothyroidism	8.14e-05	0.00112	CbGpPWpGaD
Escitalopram—HRH1—GPCR ligand binding—POMC—hypothyroidism	8.13e-05	0.00111	CbGpPWpGaD
Escitalopram—CHRM1—GPCR ligand binding—POMC—hypothyroidism	8.1e-05	0.00111	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—CLTC—hypothyroidism	8.01e-05	0.0011	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—AVP—hypothyroidism	7.98e-05	0.00109	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR ligand binding—POMC—hypothyroidism	7.97e-05	0.00109	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—IYD—hypothyroidism	7.9e-05	0.00108	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—VAV3—hypothyroidism	7.52e-05	0.00103	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TSHB—hypothyroidism	7.26e-05	0.000995	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—TSHR—hypothyroidism	7.26e-05	0.000995	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—AVP—hypothyroidism	7.24e-05	0.000993	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—VAV3—hypothyroidism	7.17e-05	0.000983	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—VAV3—hypothyroidism	7.15e-05	0.00098	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TRH—hypothyroidism	7.06e-05	0.000967	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—VAV3—hypothyroidism	7.04e-05	0.000965	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TRH—hypothyroidism	7.03e-05	0.000964	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TRH—hypothyroidism	6.93e-05	0.000949	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—AVP—hypothyroidism	6.91e-05	0.000947	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—AVP—hypothyroidism	6.89e-05	0.000944	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—AVP—hypothyroidism	6.78e-05	0.00093	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—ATP5O—hypothyroidism	6.71e-05	0.00092	CbGpPWpGaD
Escitalopram—CYP3A4—Biological oxidations—POMC—hypothyroidism	6.69e-05	0.000917	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—VAV3—hypothyroidism	6.51e-05	0.000893	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—VAV3—hypothyroidism	6.49e-05	0.00089	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—SH2B3—hypothyroidism	6.47e-05	0.000887	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—VAV3—hypothyroidism	6.39e-05	0.000876	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—TPO—hypothyroidism	6.31e-05	0.000865	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TSHB—hypothyroidism	6.29e-05	0.000862	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—TSHR—hypothyroidism	6.29e-05	0.000862	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—AVP—hypothyroidism	6.28e-05	0.00086	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TSHB—hypothyroidism	6.27e-05	0.00086	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—TSHR—hypothyroidism	6.27e-05	0.00086	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—AVP—hypothyroidism	6.26e-05	0.000858	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TSHB—hypothyroidism	6.17e-05	0.000846	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—TSHR—hypothyroidism	6.17e-05	0.000846	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—AVP—hypothyroidism	6.16e-05	0.000844	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—SH2B3—hypothyroidism	5.61e-05	0.000769	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—SH2B3—hypothyroidism	5.59e-05	0.000766	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—SH2B3—hypothyroidism	5.5e-05	0.000754	CbGpPWpGaD
Escitalopram—HTR2C—GPCR downstream signaling—POMC—hypothyroidism	5.3e-05	0.000727	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—TSHB—hypothyroidism	4.86e-05	0.000666	CbGpPWpGaD
Escitalopram—HTR2C—Signaling by GPCR—POMC—hypothyroidism	4.81e-05	0.00066	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—PRL—hypothyroidism	4.8e-05	0.000658	CbGpPWpGaD
Escitalopram—HRH1—GPCR downstream signaling—POMC—hypothyroidism	4.59e-05	0.00063	CbGpPWpGaD
Escitalopram—CHRM1—GPCR downstream signaling—POMC—hypothyroidism	4.58e-05	0.000628	CbGpPWpGaD
Escitalopram—ADRA1A—GPCR downstream signaling—POMC—hypothyroidism	4.51e-05	0.000618	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—TSHB—hypothyroidism	4.47e-05	0.000613	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—VAV3—hypothyroidism	4.44e-05	0.000609	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	4.33e-05	0.000594	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—AVP—hypothyroidism	4.28e-05	0.000587	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	4.27e-05	0.000586	CbGpPWpGaD
Escitalopram—HRH1—Signaling by GPCR—POMC—hypothyroidism	4.17e-05	0.000572	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—PRL—hypothyroidism	4.16e-05	0.00057	CbGpPWpGaD
Escitalopram—CHRM1—Signaling by GPCR—POMC—hypothyroidism	4.16e-05	0.00057	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—PRL—hypothyroidism	4.15e-05	0.000568	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling by GPCR—POMC—hypothyroidism	4.09e-05	0.000561	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—PRL—hypothyroidism	4.08e-05	0.00056	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—PIK3C2A—hypothyroidism	3.98e-05	0.000546	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—VAV3—hypothyroidism	3.85e-05	0.000527	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—VAV3—hypothyroidism	3.84e-05	0.000526	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—VAV3—hypothyroidism	3.78e-05	0.000518	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—AVP—hypothyroidism	3.71e-05	0.000508	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—AVP—hypothyroidism	3.7e-05	0.000507	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—AVP—hypothyroidism	3.64e-05	0.000499	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—SLC5A5—hypothyroidism	3.64e-05	0.000499	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—SLC5A5—hypothyroidism	3.35e-05	0.000459	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—TSHB—hypothyroidism	2.92e-05	0.000401	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—POMC—hypothyroidism	2.84e-05	0.00039	CbGpPWpGaD
Escitalopram—HTR2C—Signaling Pathways—IGF1—hypothyroidism	2.73e-05	0.000375	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	2.6e-05	0.000357	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—POMC—hypothyroidism	2.46e-05	0.000338	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—POMC—hypothyroidism	2.46e-05	0.000337	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—POMC—hypothyroidism	2.42e-05	0.000331	CbGpPWpGaD
Escitalopram—HRH1—Signaling Pathways—IGF1—hypothyroidism	2.37e-05	0.000325	CbGpPWpGaD
Escitalopram—CHRM1—Signaling Pathways—IGF1—hypothyroidism	2.36e-05	0.000324	CbGpPWpGaD
Escitalopram—ADRA1A—Signaling Pathways—IGF1—hypothyroidism	2.33e-05	0.000319	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—SLC5A5—hypothyroidism	2.19e-05	0.0003	CbGpPWpGaD
Escitalopram—CYP2C19—Metabolism—POMC—hypothyroidism	1.9e-05	0.000261	CbGpPWpGaD
Escitalopram—CYP2D6—Metabolism—POMC—hypothyroidism	1.75e-05	0.00024	CbGpPWpGaD
Escitalopram—CYP3A4—Metabolism—POMC—hypothyroidism	1.14e-05	0.000157	CbGpPWpGaD
